Angela Dispenzieri, MD
Enriched profileProfessor of Medicine and of Laboratory Medicine and Pathology; Consultant, Division of Hematology, Department of Internal Medicine (Serene M. and Frances C. Durling Professor of Medicine) · Mayo Clinic
Angela Dispenzieri is Professor of Medicine and of Laboratory Medicine and Pathology; Consultant, Division of Hematology, Department of Internal Medicine (Serene M. and Frances C. Durling Professor of Medicine) at Mayo Clinic. OpenAlex indexes 2,490 publications with 100,475 citations (h-index 146); ClinicalTrials.gov lists 13 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Hematology profiles in the findmyKOL directory. Clarivate lists Angela Dispenzieri as a Highly Cited Researcher (Clinical Medicine, 2021; Cross-Field, 2019, 2022-2023).
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Angela Dispenzieri, M.D., is Professor of Medicine and of Laboratory Medicine and Pathology at Mayo Clinic, Rochester, Minnesota. The public record shows 2,490 publications with 100,475 citations (h-index 146), centered on Multiple Myeloma Research and Treatments, Amyloidosis: Diagnosis, Treatment, Outcomes, Protein Degradation and Inhibitors. It also documents an investigator role on 13 registered clinical trials, industry payments reported by 9 companies, 5 NIH-funded awards (2001–2022).
- Most recent indexed publication: 2026 · Journal of clinical oncology
- Top research focus: Multiple Myeloma Research and Treatments
- 13 registered trials on ClinicalTrials.gov
- Open Payments reporting from 9 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 194 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 877.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:
- Artificial Intelligence Enhanced ECG to Detect Cardiac Amyloidosis
Sponsor: Mayo Clinic
Industry payments
Updated 27 Aug 2026
9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca UK LimitedProgram year20251 payment
- Regeneron Pharmaceuticals, Inc.Program year20242 payments
- Janssen Biotech, Inc.Program year20241 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
50.8%Other drugs affecting bone structure and mineralization50.8%Romosozumab-aqqg100%Part B, office-administered≥11 patientsAnti-infectives
42.6%SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor42.3%Remdesivir100%Part B, office-administered≥13 patientsShort-acting sulfonamides0.3%Sulfamethoxazole-Trimethoprim100%Part D<11 patientsCancer & immunology
2%Thalidomide Analog1.6%Revlimid66%Lenalidomide34%Part D<11 patientsBCL-2 Inhibitor0.4%Venclexta100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
5 NIH research awards on record, funded 2001–2022 per NIH RePORTER. The latest:
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials.
Journal of clinical oncology
Clinical Trial2026 - POEMS Syndrome: 2026 Update on Diagnosis, Risk-Stratification, and Management.
American journal of hematology
Article2026
Most-cited works
by citation count (OpenAlex)- 01
- 02Review of 1027 Patients With Newly Diagnosed Multiple Myeloma2,432 citations2003
- 03Improved survival in multiple myeloma and the impact of novel therapies2,252 citations2007
- 04Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis2,014 citations2016
- 05Prevalence of Monoclonal Gammopathy of Undetermined Significance1,410 citations2006
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/angela-dispenzieri-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - X / Twitter
x.com/ADispenzieri
Mentions by others
where others cite or feature them- Other
bloodcancerstoday.com/podcast/angela-dispenzieri-md-on-managing-newly-diagnosed-al-amyloidosis
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bloodcancerstoday.com ↗ - Other
vjhemonc.com/speaker/angela-dispenzieri
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vjhemonc.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Angela-Dispenzieri-2161930600
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Resident/Fellow
Hematology and Oncology, Mayo Graduate School of Medicine, Mayo Clinic College of Medicine
1998verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
- Resident
Internal Medicine, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine
1994verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
- Undergraduate study
Massachusetts Institute of Technology (per Mayo biographical summary; degree/year not specified on primary page)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
Highly Cited Researcher
Clarivate's annual list, by award category and year- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
- Cross-Field201920222023verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
Awards & honors
honors on the public record- The Joseph Michaeli Award for Outstanding Contributions to Myeloma Research
Division of Hematology and Oncology of Weill Cornell Medicine
2023verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
Secondary affiliations
appointments beyond the home institution- Department of Molecular Medicine
Mayo Clinic (joint appointment)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.usnews.com ↗ - Division of Clinical Biochemistry and Immunology
Department of Laboratory Medicine and Pathology, Mayo Clinic (joint appointment)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.usnews.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →treatingbloodcancers.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bloodcancerstoday.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vjhemonc.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
S Rajkumar, MD
Mayo Clinic
Bradley Boeve, MD
Mayo Clinic
Rick Nishimura, MD
Mayo Clinic
Victor Montori, MD
Mayo Clinic